Danielle Ruppert Wendel MD
Intestinal Rehabilitation and Small Bowel Transplantation
Pediatric Gastroenterology Seattle Children's Hospital Director, Intestinal Rehabilitation Medical Director, Intestinal Transplant
Join to view full profile
4800 Sand Point Way NESeattle Children's HospitalSeattle, WA 98105
Dr. Wendel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Danielle Wendel is a pediatric gastroenterologist in Seattle, WA and is affiliated with the University of Washington/Seattle Children's Hospital. She received her medical degree from University of Rochester, pediatric training at the University of Pittsburgh, and pediatric gastroenterology training at the Children’s Hospital of Philadelphia. She specializes in intestinal rehabilitation and small bowel transplantation.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Gastroenterology, 2012 - 2015
UPMC Medical EducationResidency, Pediatrics, 2009 - 2012
University of Rochester School of Medicine and DentistryClass of 2009
Certifications & Licensure
ID State Medical License 2021 - 2029
WA State Medical License 2015 - 2028
MT State Medical License 2018 - 2027
OR State Medical License 2020 - 2027
PA State Medical License 2009 - 2016
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
Clinical Trials
- Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study Start of enrollment: 2016 Dec 09
- Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) Start of enrollment: 2017 Jan 09
- Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Start of enrollment: 2018 Aug 31
Publications & Presentations
PubMed
- Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term exte...Susan Hill, Beth Carter, Valeria Cohran, Samuel Kocoshis, Pradeep Nazarey
Intestinal Failure. 2026-10-21 - Assessing the current landscape of North American pediatric nutrition support teams: A survey study.Rachel E Herdes, Lily Xia, Atu Agawu, Arun Ajmera, Mary Abigail S Garcia
JPGN Reports. 2026-10-12 - Safety and long-term effectiveness of teduglutide in children with intestinal failure due to short bowel syndrome: a multicenter, post-marketing cohort study.Lissette Jimenez, Aliza Ray, David Mercer, Samuel Kocoshis, Sivan Kinberg
Pediatric Research. 2026-09-17
Professional Memberships
- Member
- North American Society of Pediatric Gastroenterology, Hepatology, and Nutrtition (NASPGHAN)Member
- Intestinal Rehabilitation and Transplantation AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: